Paper18083
Azlocillin: in vitro studies of a new semisynthetic penicillin.
Stewart D and 1 other. Antimicrob Agents Chemother, 1977. Cited by 74 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Azlocillin: in vitro studies of a new semisynthetic penicillin. Papers, record 18083. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18083
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacteria | Major topic |
| Penicillins | Major topic |
| Enterobacteriaceae | |
| Hydrogen-Ion Concentration | |
| Microbial Sensitivity Tests | |
| Pseudomonas aeruginosa | |
| Staphylococcus aureus | |
| Streptococcus |
Source PubMed
References6
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,555,556 | Infections in cancer patients. Results with gentamicin sulfate therapy. | Cancer | 1972 | https://conductscience.org/library/papers/4555556 | PubMed |
| 2 | 4,580,721 | Infectious complications in renal transplant recipients. | Transplant Proc | 1973 | https://conductscience.org/library/papers/4580721 | PubMed |
| 3 | 836,016 | Mezlocillin: in vitro studies of a new broad-spectrum penicillin. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/836016 | PubMed |
| 4 | 4,930,281 | In vitro studies of semisynthetic alpha-(substituted-ureido) penicillins. | Appl Microbiol | 1971 | https://conductscience.org/library/papers/4930281 | PubMed |
| 5 | 817,665 | Pirbenicillin, a new semisynthetic penicillin with broad-spectrum activity. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/817665 | PubMed |
| 6 | 4,591,273 | Proceedings: Causes of death in cancer patients. | Cancer | 1974 | https://conductscience.org/library/papers/4591273 | PubMed |
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 74 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35,401,470 | The Chemical Relationship Among Beta-Lactam Antibiotics and Potential Impacts on Reactivity and Decomposition. | Front Microbiol | 2022 | https://conductscience.org/library/papers/35401470 | PubMed |
| 7,425,600 | Pharmacokinetics of azlocillin in subjects with normal and impaired renal function. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/7425600 | PubMed |
| 7,235,679 | CI-867, a new semisynthetic penicillin: in vitro studies. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/7235679 | PubMed |
| 7,152,688 | [Azlocillin--a new anti-pseudomonas penicillin. A review of the literature and pharmacokinetic studies]. | Infection | 1982 | https://conductscience.org/library/papers/7152688 | PubMed |
| 7,117,356 | Elimination of azlocillin in patients with biliary t-tube drainage. | Eur J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7117356 | PubMed |
| 7,002,527 | Ticarcillin: a review of its pharmacological properties and therapeutic efficacy. | Drugs | 1980 | https://conductscience.org/library/papers/7002527 | PubMed |
| 6,919,412 | Comparative in vitro study of temocillin (BRL 17421), a new penicillin. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6919412 | PubMed |
| 6,875,810 | The pharmacokinetics of furazlocillin in healthy humans. | J Pharmacokinet Biopharm | 1983 | https://conductscience.org/library/papers/6875810 | PubMed |
| 6,818,157 | The in vitro activity of beta-lactam antibiotics against gentamicin and/or carbenicillin-resistant Pseudomonas aeruginosa strains. | Infection | 1982 | https://conductscience.org/library/papers/6818157 | PubMed |
| 6,805,423 | Activities of tobramycin and azlocillin alone and in combination against experimental osteomyelitis caused by Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6805423 | PubMed |
| 6,778,383 | In vitro evaluation of Ro 13-9904. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6778383 | PubMed |
| 6,774,663 | Comparative bactericidal effects of azlocillin and ticarcillin against Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6774663 | PubMed |
| 6,771,215 | Selection of variants of Pseudomonas aeruginosa resistant of Beta-lactam antibiotics. | Infection | 1980 | https://conductscience.org/library/papers/6771215 | PubMed |
| 6,660,850 | High-pressure liquid chromatographic quantitation of azlocillin. | Antimicrob Agents Chemother | 1983 | https://conductscience.org/library/papers/6660850 | PubMed |
| 6,538,397 | Comparative efficacies of piperacillin, azlocillin, ticarcillin, aztreonam, and tobramycin against experimental Pseudomonas aeruginosa pneumonia. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6538397 | PubMed |
| 6,435,516 | In vitro activities of ureidopenicillins alone and in combination with amikacin and three cephalosporin antibiotics. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6435516 | PubMed |
| 2,751,284 | Pharmacokinetic comparison of 5 g of azlocillin every 8 h and 4 g every 6 h in healthy volunteers. | Antimicrob Agents Chemother | 1989 | https://conductscience.org/library/papers/2751284 | PubMed |
| 525,984 | Pharmacokinetics of Bay k 4999, a new broad-spectrum penicillin. | Antimicrob Agents Chemother | 1979 | https://conductscience.org/library/papers/525984 | PubMed |
| 485,123 | Comparison of the activities of the new ureidopenicillins piperacillin, mezlocillin, azlocillin, and Bay k 4999 against gram-negative organisms. | Antimicrob Agents Chemother | 1979 | https://conductscience.org/library/papers/485123 | PubMed |
| 422,252 | [Current chemotherapy of infections caused by Pseudomonas aeruginosa (author's transl)]. | Infection | 1979 | https://conductscience.org/library/papers/422252 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/18083
GET https://conductscience.org/api/papers/v1/18083/cited_by?page=2